Related Experiment Video
Updated: May 3, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Toward real-time dose-guided radiation therapy: deformable multileaf collimator tracking using motion-model-derived
Laura Esther Büttgen1,2, Chandrima Sengupta3, Jonathan R Sykes4,5
1Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Abstract:
Objective. Accurate dose delivery in the presence of anatomical motion and deformation remains a major challenge in radiation therapy. Real-time dose-guided radiation therapy addresses this challenge by integrating volumetric imaging, dose accumulation, and adaptive treatment in a quasi-continuous manner. Unlike previous studies limited to rigid motion or phantom data, this study employs a motion model to generate real-time volumetric images, enabling deformable dose-guided multileaf collimator (MLC) tracking in lung and liver cancer patients.Approach. Deformable dose-guided MLC tracking was simulated for ten patients (4 lung, 6 liver). The workflow included: (1) training a patient-specific linear regression-based motion model relating external respiratory signals (RPMs) to deformation vector fields using planning 4DCT data, (2) generating volumetric images using treatment RPM signals, (3) simulating dose-guided MLC tracking comparing deformable, rigid and no tracking, and (4) evaluating the motion model accuracy using fiducial markers and kV imaging. Dosimetric accuracy was assessed using 3D Gamma analysis (2%/2mm) and normalized root mean squared error by comparing simulated delivered dose to a motion-compensated baseline. Motion model error was quantified as the distance between predicted and ground truth marker positions.Main results. Deformable tracking significantly outperformed rigid and no tracking (p<0.001), achieving a mean Gamma passing rate of95.0±6.0%, compared to86.3±10.0%and74.8±15.2%, respectively. Lung patients showed a greater benefit in Gamma passing rate (deformable:98%vs rigid:85%, ±13%) than liver patients (93%vs89%,+4%). The dosimetric benefit correlated with respiratory amplitude, with larger motion yielding greater improvements. The motion model demonstrated high accuracy, with a mean error of0.1±2.9mm.Significance. This study demonstrates the feasibility and dosimetric advantage of deformable dose-guided MLC tracking using motion-model-derived volumetric imaging in patient data. These findings represent a critical step toward the clinical implementation of real-time dose-guided radiation therapy.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022